The landscape of securities litigation is poised for significant developments in 2026, influenced by emerging technologies, regulatory shifts, and evolving market dynamics. Legal professionals should closely monitor the following trends:
-
Artificial Intelligence (AI) and “AI-Washing” Allegations
The proliferation of AI technologies has led to increased scrutiny over corporate disclosures. Companies accused of “AI-washing”—exaggerating or misrepresenting their AI capabilities—have faced a surge in class action lawsuits. In the first half of 2025, AI-related securities cases increased by 56%, with the Disclosure Dollar Loss Index reaching $403 billion, underscoring the substantial financial implications for investors and corporations alike. This trend is particularly pronounced in the technology sector, where firms are under heightened scrutiny for alleged misrepresentations.
-
Escalation in Securities Class Action Filings and Financial Exposure
While the number of securities class action filings remained steady in the first half of 2025, the financial stakes have escalated dramatically. The Disclosure Dollar Loss (DDL) Index reached $403 billion, a 56% increase from the previous half-year, marking the highest semiannual total since the record-high set in 2022. The Maximum Dollar Loss (MDL) Index also surged to $1.851 trillion, a 154% increase from the second half of 2024. This indicates a strategic shift towards targeting larger companies with higher potential recoveries.
-
Regulatory Intensification and ESG-Related Litigation
Regulatory activity has intensified, with 70% of respondents involved in at least one regulatory proceeding in 2024, up from 61% in 2023. Environmental, Social, and Governance (ESG) initiatives are under increased scrutiny, with 27% of respondents reporting heightened exposure to ESG-related disputes. This trend is driven by both pro-ESG regulatory pressures and anti-ESG sentiments, reflecting a complex and evolving regulatory environment.
-
Sector-Specific Vulnerabilities
The consumer non-cyclical sector, particularly biotechnology and pharmaceutical companies, experienced a 31% increase in filings during the first half of 2025. This sector accounted for 62% of total disclosure losses while comprising only 44% of core filings, highlighting a disproportionate impact. Legal professionals should be aware of the heightened litigation risks in these industries.
-
Geographic Concentration of Litigation
Jurisdictions such as the Northern District of California and the Southern District of New York have become focal points for AI-related securities litigation. The Third Circuit saw its filings more than triple, driven largely by biotech and pharmaceutical cases, with a similar increase observed in the Eleventh Circuit. This geographic concentration suggests that plaintiffs’ attorneys are strategically selecting venues based on industry clusters and historical success rates.
In summary, 2026 is expected to witness a continuation of these trends, with AI-related disclosures, regulatory scrutiny, and sector-specific vulnerabilities shaping the securities litigation landscape. Legal professionals should remain vigilant and adapt their strategies to navigate this evolving environment effectively.